February 2017 Issue Table Of Contents

From The Editor

• What JPM 2017 Revealed To Me

Feature Article

• The Secrets To CSL Limited’s Incredible Revenue Growth

The Enterprisers

• CohBar - Producing Mitochondria Medicine

Capitol Perspectives

• Trump Targets The Pharmaceutical Industry

Companies To Watch

• A Progress Report On The 2016 Companies To Watch

CEO Corner

• Why More Incentives Are Needed To Tackle Antibiotic Resistance

Inside The Industry

• Getting An Accurate Count Of Counterfeit Drugs
• What To Know About Post-Grant Review And The Biotech Industry
• Most U.S. Pharmas Ignore Cuba, Despite Relaxed Rules
• What Gets Funded, What Dies Before It Gets To Pharma R&D
• Brexit Presents Opportunity For U.S. Life Sciences Companies
• The Ethical Implications Of Right-To-Try Laws
• How To Navigate Pharma Collaboration And Licensing Agreements

Leadership Lessons

• Getting Great = Confidence + Willingness

Industry Leader

• Considerations For The Use Of Wearables In Clinical Trials
• How Patients Will Revolutionize Next-Generation Clinical Research

Ask The Board

• Are There Teachings From A Small Company That Can Help Big Company Executives?
• Knowing What You Know Now, What Would You Do Differently In Managing Teams?
• What Is The Most Interesting Post-Retirement Experience You Have Had, And Why?